Join Vera Therapeutics for a hybrid R&D day, featuring Richard Lafayette, MD, FACP, from Stanford University Medical Center, who will join company management…

Join us in-person for a KOL event with Reneo Pharmaceuticals, featuring Amel Karaa, MD (Massachusetts General Hospital), PI of the…

HybridOculis: Retina R&D Day

Join us in-person or virtually for the Oculis Retina R&D Day, featuring multiple retina KOLs who will discuss the unmet…
Dr. Paul Y. Song, CEO of NKGen Biotech, Inc. & James Graf, CEO of Graf Acquisition Corp. IV Featured Presentation…

Join us in-person for a KOL Breakfast with Protalix Biotherapeutics, discussing the recent FDA approval of Elfabrio® (pegunigalsidase alfa-iwxj) in…

8:30 AM ET – Breakfast/Check-In 9:00 AM ET – 11:00 AM ET - Presentations Y-mAbs Therapeutics invites you to their…